Pre-treatment 111In-pentetreotide SPECT/CT vs. baseline 177Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?
{{output}}
Background: 111In-pentetreotide imaging remains used for pre-treatment screening in peptide receptor radionuclide therapy (PRRT) in regions where somatostatin receptor (SSTR)-PET tracers are clinically unavailable. Post-treatment... ...
